Android app on Google Play

UBS Downgrades Teva Pharma (TEVA) to Neutral

December 3, 2012 6:41 AM EST Send to a Friend
Get Alerts TEVA Hot Sheet
Price: $52.52 --0%

Rating Summary:
    15 Buy, 15 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade TEVA Now!
Join SI Premium – FREE
UBS downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $40.35 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

UBS

Add Your Comment